F-star Therapeutics, Inc. ROE 2016-2022 | FSTX
Current and historical return on equity (ROE) values for F-star Therapeutics, Inc. (FSTX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2022-09-30 | $-0.04B | $0.06B | -56.05% |
| 2022-06-30 | $-0.04B | $0.07B | -42.65% |
| 2022-03-31 | $-0.03B | $0.09B | -35.29% |
| 2021-12-31 | $-0.03B | $0.10B | -38.63% |
| 2021-09-30 | $-0.05B | $0.09B | -67.42% |
| 2021-06-30 | $-0.04B | $0.10B | -75.90% |
| 2021-03-31 | $-0.03B | $0.04B | -94.12% |
| 2020-12-31 | $-0.03B | $0.04B | -89.29% |
| 2020-09-30 | $-0.02B | $0.02B | -112.82% |
| 2020-06-30 | $-0.03B | $0.02B | -101.96% |
| 2020-03-31 | $-0.03B | $0.03B | -78.74% |
| 2019-12-31 | $-0.02B | $0.01B | -60.93% |
| 2019-09-30 | $-0.02B | $0.04B | -44.44% |
| 2019-06-30 | $-0.02B | $0.05B | -44.24% |
| 2019-03-31 | $-0.02B | $0.05B | -46.00% |
| 2018-12-31 | $-0.02B | $0.06B | -50.83% |
| 2018-09-30 | $-0.02B | $0.06B | -47.50% |
| 2018-06-30 | $-0.02B | $0.03B | -64.12% |
| 2018-03-31 | $-0.03B | $0.03B | -73.24% |
| 2017-12-31 | $-0.03B | $0.04B | -93.33% |
| 2017-09-30 | $-0.03B | $0.03B | -113.73% |
| 2017-06-30 | $-0.02B | $0.04B | -104.76% |
| 2017-03-31 | $-0.02B | $0.01B | -115.25% |
| 2016-12-31 | $-0.02B | $0.02B | -121.43% |
| 2016-09-30 | $-0.02B | $0.01B | -152.00% |
| 2016-06-30 | $-0.02B | $0.02B | -200.00% |
| 2016-03-31 | $-0.02B | $0.01B | -336.84% |
| 2015-12-31 | $-0.01B | $0.01B | -400.00% |
